Shire/Avexa Expand Agreement On HIV Candidate Apricitabine
This article was originally published in The Pink Sheet Daily
Executive Summary
Acquisition of North American marketing rights to the novel nucleoside reverse transcriptase inhibitor gives Australian biotech Avexa worldwide commercialization rights.